Clinical Trial Detail

NCT ID NCT03193190
Title A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

pancreatic ductal adenocarcinoma

Therapies

Atezolizumab + BKT140

Fluorouracil + Gemcitabine + Leucovorin + Nab-paclitaxel + Oxaliplatin + Pembrolizumab

Atezolizumab + PEGPH20

Atezolizumab + Cobimetinib

Age Groups: adult senior

No variant requirements are available.